US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Tobramycin 660mg in Ns 66ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0317-2023
Class II · Moderate risk Terminated

Sodium Chloride 0.9 %

Reason Lack of sterility assurance

Sentara Infusion Services D-0316-2023
Class II · Moderate risk Terminated

Piperacillin / Tazobactam

Reason Lack of sterility assurance

Sentara Infusion Services D-0315-2023
Class II · Moderate risk Terminated

Penicillin

Reason Lack of sterility assurance

Sentara Infusion Services D-0314-2023
Class II · Moderate risk Terminated

Pantoprazole 30mg in Ns 7.5ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0313-2023
Class II · Moderate risk Terminated

Ondansetron 8mg in Ns 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0312-2023
Class II · Moderate risk Terminated

Nalbuphine

Reason Lack of sterility assurance

Sentara Infusion Services D-0311-2023
Class II · Moderate risk Terminated

Nafcillin 24gm in Ns 1200ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0310-2023
Class II · Moderate risk Terminated

Mycamine 100mg in Ns 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0309-2023
Class II · Moderate risk Terminated

MORPHINE Sulfate

Reason Lack of sterility assurance

Sentara Infusion Services D-0308-2023
Class II · Moderate risk Terminated

Milrinone

Reason Lack of sterility assurance

Sentara Infusion Services D-0307-2023
Class II · Moderate risk Terminated

Metronidazole 500mg 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0306-2023
Class II · Moderate risk Terminated

Methadone

Reason Lack of sterility assurance

Sentara Infusion Services D-0304-2023
Class II · Moderate risk Terminated

Meropenem

Reason Lack of sterility assurance

Sentara Infusion Services D-0303-2023
Class II · Moderate risk Terminated

Levaquin 750MG IN D5W 150ML

Reason Lack of sterility assurance

Sentara Infusion Services D-0301-2023
Class II · Moderate risk Terminated

Intralipid 18gm

Reason Lack of sterility assurance

Sentara Infusion Services D-0298-2023
Class II · Moderate risk Terminated

Hydromorphone

Reason Lack of sterility assurance

Sentara Infusion Services NDC 00703-0018-01 D-0296-2023
Class II · Moderate risk Terminated

Ganciclovir

Reason Lack of sterility assurance

Sentara Infusion Services D-0294-2023
Class II · Moderate risk Terminated

Fluconazole 200mg Ns 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0293-2023